Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Parsacl… Recruiting

2022-501687-18-00 Advanced malignancies and IAI diseases 4 2020-10-28
Stem cell transplantation in diffuse cutaneous systemic sclerosis: upfront therapy or rescue therapy after failure of immunosuppressants Recruiting

2023-505877-34-00 Diffuse cutaneous systemic sclerosis according to the A 6 2020-08-18
A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zos… Recruiting

2022-502784-37-00 Prevention of Herpes Zoster in immunocompromised subjec 4 2019-09-03
Evaluation of the Pharmacokinetics and Safety of Upadacitinib in Pediatric Subjects with Polyarticular Course Juvenile Idiopathic Arthritis … Recruiting

2023-505060-11-00 Polyarticular Course Juvenile Idiopathic Arthritis 3 2019-06-19
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Grass pollen induced allergic rhinitis or rhinoconjunct 10 2026-06-01
Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement Recruiting

2024-519620-24-01 ANCA-associated vasculitis 5 2026-06-01
Anti-B-cell therapy in RA-ILD Recruiting

2025-524872-51-00 Rheumatoid arthritis-associated interstitial lung disea 6 2026-05-25
SAR447971 first-in-human study Recruiting

2026-525333-22-00 Hidradenitis 1 2026-05-22
A Study to understand the Effectiveness, Safety, and what the body does to Mosunetuzumab in participants with Systemic Lupus Erythematosus w… Recruiting

2024-519930-22-00 Systemic Lupus Erythematosus (SLE) With or Without Acti 4 2026-05-18
Dual wavelength fluorescence imaging using fluorescently labelled adalimumab and risankizumab for visualizing drug targeting in Inflammatory… Recruiting

2025-521420-30-00 Inflammatory Bowel Disease (IBD) 9 2026-05-08
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus E… Recruiting

2025-523552-31-00 Systemic Lupus Erythematosus 5 2026-05-07
A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune medi… Recruiting

2026-525575-22-00 Psoriasis 1 2026-05-07
A novel fibroblast imaging biomarker and ultrahigh resolution PET to improve the diagnosis and follow-up of giant cell arteritis Recruiting

2025-523880-39-02 Giant Cell Arteritis 10 2026-05-04
A clinical trial of MK-6050 in healthy participants (MK-6050-002) Recruiting

2026-525625-21-00 Hidradenitis suppurativa 3 2026-04-28
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa Recruiting

2025-522440-41-00 Hidradenitis Suppurativa 4 2026-04-27
Macrophage and monocyte presence in lupus nephritis before and during treatment Recruiting

2025-522187-32-01 Lupus Nephritis 6 2026-04-23
Guselkumab intervention and diet evaluation for pouchitis Recruiting

2025-521683-35-00 Pouchitis 6 2026-04-21
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults Recruiting

2025-523759-76-01 Rheumatoid arthritis and Systemic Lupus Erythematosus 1 2026-04-15
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from house dust mite allergy. A prosp… Recruiting

2025-523119-12-00 Patients with moderate-to-severe allergic rhinitis / rh 10 2026-04-02
Phase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321 Recruiting

2025-524053-14-00 Graves Disease 1 2026-04-02
Systematic Adjunction of Vasopressine in hyperkinetic Septic Shock patients: a prospective, randomized, double blind study. Recruiting

2024-513401-31-00 Septic shock 5 2026-03-24
Not Applicable Recruiting

2024-511198-31-00 Lupus Nephritis 10 2026-03-24
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting

2025-521036-11-00 Immune system disseases 5 2026-03-23
A study to learn about the effectiveness and safety of different doses of JNJ-88545223 in people with active psoriatic arthritis Recruiting

2025-523141-10-00 Active Psoriatic Arthritis 4 2026-03-20